clonoSEQ Publications

View publications relating to FDA-cleared clonoSEQ® Assay, a highly sensitive, specific, and standardized test for detecting and monitoring MRD, or measurable residual disease, in B-cell acute lymphoblastic leukemia (ALL) and multiple myeloma (MM).

back_to_top